NL-OMON49894已完成不适用
OUTER SPACE-2: a randomised study on inhaler treatment adherence using a smart spacer in adults with asthma - OUTERSPACE-2
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1) adults >= 18 years;
- •(2) physician diagnosed asthma treated in primary care;
- •(3) using any inhaled corticosteroid (ICS) (+/-long-acting beta agonist [LABA]
- •+/- short-acting beta agonist [SABA]) administered by a pressurized Metered
- •Dose Inhaler (pMDI) and a spacer;
- •(4) willing to sign informed consent.
排除标准
- •(1) < 18 years;
- •(2) exacerbation in the last 3 months (defined as use of antibiotics and/or
- •prednisone short-course and/or admission to a ED or hospital).
研究者
相似试验
尚未招募
不适用
OUTER SPACE: a randomised study on inhaler treatment adherence using a smart spacer in adults with asthmaasthmaNL-OMON24135MCG40
已完成
不适用
OUTER SPACE: A pilot study on inhaler treatment adherence using a smart spacer in adults with COPDCOPDNL-OMON27015Trudell medical12
已完成
不适用
Inhalation of heated, humidified air (rhinothermy) in the common cold: a feasibility studyInfection - Other infectious diseasesCommon coldACTRN12616000470493Fisher & Paykel Healthcare30
已完成
2 期
Effect of inhaled pharmaceutical Penthrox (Methoxyflurane) on pain of limb fractureCondition 1: Sequelae of fracture of arm. Condition 2: Sequelae of other fractures of lower limb.Sequelae of injury classifiable to S42.-, S52.- and T10Sequelae of injury classifiable to S82.-, S92.- and T12IRCT2015111724799N3Vice chancellor for research, Baqiyatallah University of Medical Sciences100
进行中（未招募）
1 期
Trial to test the safety, half-life, and antiviral efficacy of a new drug (human antibody) called DZIF-10c (administered inhalatively) in healthy volunteers and SARS-CoV-2-infected participantsSARS-CoV-2 infection (only mild to moderate disease)MedDRA version: 23.0Level: LLTClassification code 10084272Term: SARS-CoV-2 infectionSystem Organ Class: 100000004862EUCTR2020-004448-27-DEniversity of Cologne96